The length of hospital stays and death among patients with chronic obstructive pulmonary disease are tied to various ...

A morning cough may be an annoyance, but it could also be a sign of a more serious lung condition. But if the bloating is a ...

Researchers have confirmed in a new study that common nasal diseases, such as allergic rhinitis and nasal polyps, are highly ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today topline results from the pivotal Phase ...

Midlife weight loss was associated with decreased risks for all-cause mortality, cardiovascular disease, and chronic disease beyond diabetes.

Chronic obstructive pulmonary disease (COPD) is the third leading cause of death globally and remains a major public health ...

Britain's GSK and China's Jiangsu Hengrui Pharmaceuticals have agreed on a $500 million deal to develop up to a dozen new ...

GSK signed a 12-asset licensing deal with Hengrui Pharma. Generic erosion on Vyvanse continued to hurt Takeda. Celltrion is ...

A lack of vitamin D can cause a predisposition to bone fractures, muscle and bone aches and pains, and fatigue. It can even ...

(Reuters) -Regeneron Pharmaceuticals beat Wall Street estimates for second-quarter revenue and profit on Friday helped by ...

While numerous studies have assessed how much people with chronic obstructive pulmonary disease (COPD) walk, few have explored how they walk, especially in unsupervised, ...

The pivotal phase IIb ALIENTO study met the primary endpoint of a statistically significant reduction in the annualised exacerbation rate (AER) at 52 weeks when astegolimab was given every two weeksTh ...